Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065321Phase 4Completed
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Hefei First People's Hospital. Primary endpoints: Postoperative muscle strength and Postoperative pain. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065321.